Replies to post #2756 on BrainStorm Cell Therapeutics Inc (BCLI)

[midastouch017]

a stock valuation of $33 per share.

Excellent. Very encouraging, however for me
it is not really important. I am in at lest
till [positive] results phase III als.

:-)